on a la santé
Location:
France
War freq.:
oncePerWeek
Members:
7/50
Level:
2
Win/Tie/Loss:
3/0/9
Points:
5754
Streak:
0
Trophies:
0
| Level | Name | Donations | Received | Trophies | |
|---|---|---|---|---|---|
|
148 | Kesh Co-Leader | 0 | 0 | 2181 |
|
|
150 | MS10 Co-Leader | 0 | 0 | 1934 |
|
|
116 | theodu35220 Co-Leader | 0 | 0 | 1930 |
|
|
108 | charlie Elder | 0 | 0 | 1867 |
|
|
107 | GAGOU DU 35 Leader | 0 | 0 | 1717 |
|
|
69 | sablito Co-Leader | 0 | 0 | 967 |
|
|
60 | Vivin Co-Leader | 0 | 0 | 916 |
| Clan | Result | Opponent | Date | ||
|---|---|---|---|---|---|
|
War clan
CDCM B
84 xp 85.3 % 25 |
|
lose
10 vs 10 |
|
(بركان الغضب)
26 92.4 % |
2022-12-06
808d ago
|
|
War clan
CDCM B
100 xp 76.2 % 20 |
|
lose
10 vs 10 |
|
After the cloud
21 83.9 % |
2022-11-30
814d ago
|
|
War clan
CDCM B
97 xp 75.9 % 21 |
|
lose
10 vs 10 |
|
Hayırsızlar
26 95.6 % |
2022-11-28
816d ago
|
|
War clan
CDCM B
96 xp 74.8 % 20 |
|
lose
10 vs 10 |
|
Turbocuite
26 87.8 % |
2022-11-25
819d ago
|
|
War clan
CDCM B
158 xp 87.8 % 26 |
|
win
10 vs 10 |
|
خسته شب rr
13 53.6 % |
2022-11-23
821d ago
|
|
War clan
CDCM B
98 xp 87.1 % 24 |
|
lose
10 vs 10 |
|
MADA ELEPHANT
25 88.4 % |
2022-11-21
823d ago
|
|
War clan
CDCM B
105 xp 82.8 % 25 |
|
lose
10 vs 10 |
|
Dark Souls
25 95.4 % |
2022-11-09
835d ago
|
|
War clan
CDCM B
103 xp 82.5 % 22 |
|
lose
10 vs 10 |
|
ONLINE
23 91.4 % |
2022-11-07
837d ago
|
|
War clan
CDCM B
149 xp 89.4 % 25 |
|
win
10 vs 10 |
|
*ⓚⓐⓟⓦⓐ_ⓟⓡⓘⓓⓔ*
12 42 % |
2022-11-05
839d ago
|
|
War clan
CDCM B
158 xp 82.7 % 23 |
|
win
10 vs 10 |
|
Death•ANGEL
22 83.2 % |
2022-11-03
841d ago
|
|
War clan
CDCM B
44 xp 55 % 13 |
|
lose
10 vs 10 |
|
PYRIET KINGS™
22 87.8 % |
2022-10-25
850d ago
|
|
War clan
CDCM B
71 xp 81 % 17 |
|
lose
10 vs 10 |
|
Mountain Dogs
26 92.5 % |
2022-10-23
852d ago
|
| Event | Time |
|---|
This content is not affiliated with, endorsed, sponsored, or specifically approved by Supercell and Supercell is not responsible for it. For more information see Supercell’s Fan Content Policy: www.supercell.com/fan-content-policy. This website uses cookies and may store your personal information, more details in Privacy Policy.